Comparative study of the 7th and 8th AJCC editions for gastric cancer patients after curative surgery

被引:18
作者
Fang, Wen-Liang [1 ,2 ]
Huang, Kuo-Hung [1 ,2 ,3 ]
Chen, Ming-Huang [2 ,4 ]
Liu, Chien-An [2 ,5 ]
Hung, Yi-Ping [2 ,4 ]
Chao, Yee [2 ,4 ]
Tai, Ling-Chen [1 ,2 ]
Lo, Su-Shun [2 ,6 ]
Li, Anna Fen-Yau [2 ,7 ]
Wu, Chew-Wun [1 ,2 ]
Shyr, Yi-Ming [1 ,2 ]
机构
[1] Taipei Vet Gen Hosp, Div Gen Surg, Dept Surg, Taipei, Taiwan
[2] Natl Yang Ming Univ, Schoole Med, Taipei, Taiwan
[3] Natl Yang Ming Univ, Inst Clin Med, Sch Med, Taipei, Taiwan
[4] Taipei Vet Gen Hosp, Div Med Oncol, Dept Oncol, Taipei, Taiwan
[5] Taipei Vet Gen Hosp, Dept Radiol, Taipei, Taiwan
[6] Natl Yang Ming Univ Hosp, Yilan, Taiwan
[7] Taipei Vet Gen Hosp, Dept Pathol, Taipei, Taiwan
来源
PLOS ONE | 2017年 / 12卷 / 11期
关键词
EXTENDED PARAAORTIC LYMPHADENECTOMY; D2; TRIAL; DISSECTION; MORTALITY; MORBIDITY;
D O I
10.1371/journal.pone.0187626
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Objectives The classification of pathological tumor-node-metastasis (pTNM) staging of gastric cancer was revised in the 8th American Joint Committee on Cancer (AJCC) edition. The major revision was the separation of pN3a and pN3b in the pTNM staging. The current study evaluated the prognostic impact of this change. Methods A total of 1,517 patients who underwent curative surgery for gastric cancer with a retrieved lymph node number >= 15 at our institution from January 1995 to December 2011 were enrolled. Survival was compared for the disease classified according to both the 7th and 8th editions. Results After separation of pN3a and pN3b in the pTNM stage definition, the 8th edition still provides significant survival differences between each stage. The multivariate analysis demonstrated that the pTNM stage in both the 7th and 8th editions was an independent prognostic factors of overall survival and disease-free survival. The 8th edition has a better homogeneity than the 7th edition with a significantly higher likelihood ratio chi-square test. Regarding the OS and DFS, the time-dependent receiver operating characteristic (ROC) curves of the two staging systems are almost overlapping, indicating that the prognostic performance is comparable between the two staging systems. Conclusions Both the 7th and 8th edition-based stages are independent prognostic factors for gastric cancer. The 8th edition has a better homogeneity than the 7th edition; the 8th edition providesdiscriminant survival differences among each pTNM stage that are comparable to those in the 7th edition.
引用
收藏
页数:13
相关论文
共 10 条
  • [1] Evaluation of the Seventh American Joint Committee on Cancer/International Union Against Cancer Classification of Gastric Adenocarcinoma in Comparison With the Sixth Classification
    Ahn, Hye Seong
    Lee, Hyuk Joon
    Hahn, Seokyung
    Kim, Woo Ho
    Lee, Kuhn Uk
    Sano, Takeshi
    Edge, Stephen B.
    Yang, Han-Kwang
    [J]. CANCER, 2010, 116 (24) : 5592 - 5598
  • [2] Comparison of the Survival Difference Between AJCC 6th and 7th Editions for Gastric Cancer Patients
    Fang, Wen-Liang
    Huang, Kuo-Hung
    Chen, Jen-Hao
    Lo, Su-Shin
    Hsieh, Mao-Chih
    Shen, King-Han
    Li, Anna Fen-Yau
    Niu, Dau-Ming
    Chiou, Shih-Hwa
    Wu, Chew-Wun
    [J]. WORLD JOURNAL OF SURGERY, 2011, 35 (12) : 2723 - 2729
  • [3] Esophagogastric Junction Adenocarcinoma According to Siewert Classification in Taiwan
    Fang, Wen-Liang
    Wu, Chew-Wun
    Chen, Jen-Hao
    Lo, Su-Shin
    Hsieh, Mao-Chih
    Shen, King-Han
    Hsu, Wen-Hu
    Li, Anna Fen-Yau
    Lui, Wing-Yiu
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2009, 16 (12) : 3237 - 3244
  • [4] Comparison of the current AJCC-TNM numeric-based with a new anatomical location-based lymph node staging system for gastric cancer: A western experience
    Galizia, Gennaro
    Lieto, Eva
    Auricchio, Annamaria
    Cardella, Francesca
    Mabilia, Andrea
    Diana, Anna
    Castellano, Paolo
    De Vita, Ferdinando
    Orditura, Michele
    [J]. PLOS ONE, 2017, 12 (04):
  • [5] Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine
    Sakuramoto, Shinichi
    Sasako, Mitsuru
    Yamaguchi, Toshiharu
    Kinoshita, Taira
    Fujii, Masashi
    Nashimoto, Atsushi
    Furukawa, Hiroshi
    Nakajima, Toshifusa
    Ohashi, Yasuo
    Imamura, Hiroshi
    Higashino, Masayuki
    Yamamura, Yoshitaka
    Kurita, Akira
    Arai, Kuniyoshi
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (18) : 1810 - 1820
  • [6] Gastric cancer surgery: Morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy - Japan Clinical Oncology Group Study 9501
    Sano, T
    Sasako, M
    Yamamoto, S
    Nashimoto, A
    Kurita, A
    Hiratsuka, M
    Tsujinaka, T
    Kinoshita, T
    Arai, K
    Yamamura, Y
    Okajima, K
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 2767 - 2773
  • [7] Proposal of a new stage grouping of gastric cancer for TNM classification: International Gastric Cancer Association staging project
    Sano, Takeshi
    Coit, Daniel G.
    Kim, Hyung Ho
    Roviello, Franco
    Kassab, Paulo
    Wittekind, Christian
    Yamamoto, Yuko
    Ohashi, Yasuo
    [J]. GASTRIC CANCER, 2017, 20 (02) : 217 - 225
  • [8] D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer
    Sasako, Mitsuru
    Sano, Takeshi
    Yamamoto, Seiichiro
    Kurokawa, Yukinori
    Nashimoto, Atsushi
    Kurita, Akira
    Hiratsuka, Masahiro
    Tsujinaka, Toshimasa
    Kinoshita, Taira
    Arai, Kuniyoshi
    Yamamura, Yoshitaka
    Okajima, Kunio
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (05) : 453 - 462
  • [9] Yonemura Y, 2006, HEPATO-GASTROENTEROL, V53, P389
  • [10] Randomized clinical trial of D2 and extended paraaortic lymphadenectomy in patients with gastric cancer
    Yonemura, Yutaka
    Wu, Cheng-Chung
    Fukushima, Norimasa
    Honda, Ichirou
    Bandou, Etsurou
    Kawamura, Taiichi
    Kamata, Tohru
    Kim, Byung-Sik
    Matsuki, Nobuo
    Sawa, Toshiharu
    Noh, Sung-Hoon
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2008, 13 (02) : 132 - 137